Medical Device Design Controls Training Course

FDA design control expectations require manufacturers to establish and maintain procedures that control device design. Core activities include design and development planning, design inputs, outputs, review, verification, validation, design transfer, design changes, and a design history file. The records should demonstrate that user needs, intended use, safety, and regulatory requirements were systematically translated into a device that meets defined requirements.

The common stages are design planning; defining design inputs; producing and reviewing design outputs; verification; validation; design transfer; design-change control; and compiling the design history file. Activities may overlap during development, but each stage needs defined responsibilities, acceptance criteria, review points, and documented evidence. Risk management should inform decisions throughout the lifecycle rather than being treated as a separate final-stage activity.

Yes. ISO 13485:2016 addresses design and development in clause 7.3. It requires documented procedures for planning, inputs, outputs, review, verification, validation, transfer, and control of design and development changes. The standard also expects organizations to maintain records that demonstrate requirements were met. Medical device teams commonly align these controls with risk-management activities and applicable regulatory requirements for their markets.

Key phases begin with a documented development plan and clear design inputs, then progress through design outputs, formal reviews, verification, and validation. Before commercialization, teams complete design transfer so production specifications are properly established. Controlled changes and a complete design history file support traceability after launch. Effective processes link each phase to risk decisions, objective evidence, and defined approval responsibilities.

This training is suited to medical device quality managers, regulatory affairs professionals, design engineers, project leaders, and cross-functional contributors who create, review, or approve development records. It is particularly useful for teams working under ISO 13485 and FDA quality-system expectations. Participants benefit most when they can apply lessons to active development projects, design history files, risk files, or remediation work.

Design control training helps teams understand what auditors examine: defined procedures, traceability from inputs through validation, objective evidence of reviews, and controlled design changes. QMS Learning adds an AI Workbench, manager visibility, and Audit-Evidence Package export to support application and recordkeeping. The goal is not simply course completion; it is a team that can explain decisions, locate evidence, and respond constructively to audit questions.

The Medical Device & Life Sciences QMS Training Pathway is planned as a pilot cohort opening in Q3 2026. It bundles ISO 13485 Medical Device QMS, FDA 21 CFR Part 820, ISO 14971 Risk Management, and HIPAA Privacy & Security learning. The pathway is designed for medical device QMS managers and regulatory affairs professionals who need connected coverage across major quality, risk, and privacy obligations.

A design history file typically contains, or references, records showing that development followed the approved design plan and applicable procedures. This includes design inputs and outputs, review records, verification and validation evidence, risk-management links, design-transfer records, and approved design changes. The file should provide clear traceability and make it possible for an auditor to understand how the final device design was developed and controlled.